1). Current AF therapies include several ion channel blockers that have proarrhythmic potential by non-discriminating interactions with ion channels in the heart. Because CKD-510 does not directly ...
rather than by blocking the channel pore as most KCNQ2 inhibitors do, offering a new mechanism for modulating voltage-gated ion channels with implications for drug discovery.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback